What’s more, TGF-β promoted infiltration of immune cells and cancer-associated fibroblasts in the tumor microenvironments [54], and our present study showed that HSD17B6 could inhibit the expression of TGFB1 (Fig. 15). The gene discussed is TGFB1; the disease is cancer.